High-dose cisplatin and dacarbazine in the treatment of metastatic melanoma

J Natl Cancer Inst. 1990 Dec 19;82(24):1934-7. doi: 10.1093/jnci/82.24.1934.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cisplatin / administration & dosage
  • Dacarbazine / administration & dosage
  • Female
  • Humans
  • Male
  • Melanoma / drug therapy*
  • Middle Aged
  • Neoplasm Metastasis
  • Remission Induction
  • Sex Factors

Substances

  • Dacarbazine
  • Cisplatin